Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

V Ramanan, Athimalaipet; D. Dick, Andrew; P Jones, Ashley; McKay, Andrew; Williamson, Paula; Compeyrot‐Lacassagne, Sandrine; Hardwick, Ben; Hickey, Helen; Hughes, Dyfrig; Woo, Patricia; Benton, Diana; Edelsten, Clive; W. Beresford, Michael

doi:10.1056/nejmoa1614160

Public

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

Published in New England Journal of Medicine • Apr 26, 2017

Authors:

Athimalaipet V Ramanan

Andrew D. Dick

Ashley P Jones

Abstract

BACKGROUND: Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, is effective in the treatment of juvenile idiopathic arthritis (JIA). We tested the efficacy of adalimumab in the treatment of JIA-associated uveitis. METHODS: In this multicenter, double-blind, randomized, place...

Subject

Medicine

Adalimumab

Uveitis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!